Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1042034
rs1042034
0.010 GeneticVariation BEFREE The A allele of rs1042034 and the G allele of rs676210 may thus predispose middle-aged and elderly members of the Chinese Yugur population to HL in combination with other genetic or nutritional factors, and could be used as new genetic markers for HL screening. 28902930

2017

dbSNP: rs10455872
rs10455872
LPA
0.010 GeneticVariation BEFREE Topics enriched for CVD and hyperlipidemia had positive correlations with rs10455872 (P < 0.001), replicating a previous finding. 30759150

2019

dbSNP: rs1048943
rs1048943
0.010 GeneticVariation BEFREE Hyperlipidemia could modulate the effect of CYP1A1 rs1048943 on the periodontal status of GAgP. 31032950

2019

dbSNP: rs10748835
rs10748835
0.010 GeneticVariation BEFREE The current study was to determine if coronary heart disease, hypertension, and hyperlipidemia were associated with low-level arsenic exposure and AS3MT gene single nucleotide polymorphism (SNP) A35991G (rs10748835) in rural Texas. 22341486

2012

dbSNP: rs11066280
rs11066280
0.010 GeneticVariation BEFREE Three gene variants, rs12229654, rs17249754, and rs11066280, were significantly associated with metabolic disorders such as hyperlipidemia and diabetes (P = 0.00071 to 0.0097, respectively). 24142389

2014

dbSNP: rs1137101
rs1137101
0.010 GeneticVariation BEFREE Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia. 26984935

2017

dbSNP: rs11542041
rs11542041
0.010 GeneticVariation BEFREE This explains the significant effect of the apoE gene locus on the variability of plasma lipoprotein concentrations and moreover the implication of apoE alleles in the aetiology of multifactorial forms of hyperlipidaemia e.g. familial type III hyperlipidaemia (apoE2; arg158----cys) and polygenic hypercholesterolaemia (apoE4; cys112----arg). 3141688

1988

dbSNP: rs11575937
rs11575937
0.010 GeneticVariation BEFREE Heterozygosity for LMNA R482Q mutation causes FPLD, which is associated with increased risk of hyperlipidemia and hypertension. 23313286

2013

dbSNP: rs11615
rs11615
0.010 GeneticVariation BEFREE Multiplicative interactions among SNP rs11615, alcohol drinking, history of T2DM, and history of hyperlipidemia could increase 5.06-fold risk of CAD (P = 1.59 × 10<sup>-9</sup>). 28743890

2017

dbSNP: rs1217691063
rs1217691063
0.010 GeneticVariation BEFREE MTHFR C677T genetic variant contributes to simvastatin's effects among Chinese subjects with primary hyperlipidemia. 23865383

2013

dbSNP: rs121918392
rs121918392
0.010 GeneticVariation BEFREE A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys). 12069856

2002

dbSNP: rs121964971
rs121964971
CBS
0.010 GeneticVariation BEFREE Furthermore, we characterized monocyte heterogeneity in Tg-hCBS apoE(-/-) Cbs(-/-) mice and another severe HHcy mouse model (Tg-S466L Cbs(-/-)) with a disease-relevant mutation (Tg-S466L) that lacks hyperlipidemia. 19858416

2009

dbSNP: rs12229654
rs12229654
0.010 GeneticVariation BEFREE Three gene variants, rs12229654, rs17249754, and rs11066280, were significantly associated with metabolic disorders such as hyperlipidemia and diabetes (P = 0.00071 to 0.0097, respectively). 24142389

2014

dbSNP: rs1251035592
rs1251035592
0.010 GeneticVariation BEFREE The SLCO1B1 521T > C and 388A > G variants were found to be relatively common in Chinese patients with essential hyperlipidemia. 23263738

2013

dbSNP: rs1256046734
rs1256046734
0.010 GeneticVariation BEFREE LEPR Q223R polymorphism, but not LEP G2548A, could modulate the efficacy of simvastatin in Chinese patients with primary hyperlipidemia. 26984935

2017

dbSNP: rs1256049
rs1256049
0.010 GeneticVariation BEFREE 1082A>G (rs1256049) and 1730A>G (rs4986938) showed no statistical association with hyperlipidemia. 19927160

2010

dbSNP: rs13281615
rs13281615
0.010 GeneticVariation BEFREE In premenopausal women, two environmental factors (history of breastfeeding, and history of benign breast disease) and four genetic variants (TOX3-rs3803662, ESR1-rs2046210, 8q24-rs13281615, and SLC4A7-rs4973768) were considered to be risk predictors, whereas three environmental factors (body mass index, history of breastfeeding, and hyperlipidemia), serum levels of testosterone and 25-hydroxyvitamin D, and two genetic variants (TOX3-rs3803662 and ESR1-rs2046210) were identified as risk predictors. 29029469

2017

dbSNP: rs1341991169
rs1341991169
LPL
0.010 GeneticVariation BEFREE A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys). 12069856

2002

dbSNP: rs140808909
rs140808909
0.010 GeneticVariation BEFREE Characterization of apolipoprotein E7 (Glu(244)-->Lys, Glu(245)--->Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis. 9925654

1999

dbSNP: rs1444332461
rs1444332461
0.010 GeneticVariation BEFREE To investigate the distribution of statin therapy correlated gene polymorphism allele CYP2D6*10 (C188T) in Ningxia Hui nationality and to discuss the relationship between the gene polymorphism allele CYP2D6*10 (C188T) and the lipid-lowering efficacy of simvastatin and hyperlipidemia. 24156754

2014

dbSNP: rs150599989
rs150599989
0.010 GeneticVariation BEFREE Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. 16627811

2006

dbSNP: rs17249754
rs17249754
0.010 GeneticVariation BEFREE Three gene variants, rs12229654, rs17249754, and rs11066280, were significantly associated with metabolic disorders such as hyperlipidemia and diabetes (P = 0.00071 to 0.0097, respectively). 24142389

2014

dbSNP: rs174537
rs174537
0.010 GeneticVariation BEFREE Among four SNPs, only rs174537G>T differed in allele frequencies between controls and CAD patients after adjustment for age, BMI, cigarette smoking, alcohol consumption, hypertension, diabetes mellitus, and hyperlipidemia (P=0.017). 21040914

2011

dbSNP: rs174547
rs174547
0.010 GeneticVariation BEFREE The CC variant of rs174547 was significantly associated with hyperlipidemia compared with the TT variant (adjusted odds ratio (OR)=1.71, 95% confidence intervals (CI): 1.16-2.54). 22490578

2012

dbSNP: rs1799883
rs1799883
0.010 GeneticVariation BEFREE In conclusion, no major difference was associated with the beta3AR Trp64Arg or FABP2 Ala54Thr polymorphism in terms of type 2 diabetes or hyperlipidemia in young to older Japanese men. 11699048

2001